1. Home
  2. GNTY vs ESPR Comparison

GNTY vs ESPR Comparison

Compare GNTY & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTY
  • ESPR
  • Stock Information
  • Founded
  • GNTY 1913
  • ESPR 2008
  • Country
  • GNTY United States
  • ESPR United States
  • Employees
  • GNTY N/A
  • ESPR N/A
  • Industry
  • GNTY Major Banks
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNTY Finance
  • ESPR Health Care
  • Exchange
  • GNTY Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • GNTY 520.5M
  • ESPR 437.5M
  • IPO Year
  • GNTY 2017
  • ESPR 2013
  • Fundamental
  • Price
  • GNTY $48.63
  • ESPR $2.18
  • Analyst Decision
  • GNTY Buy
  • ESPR Buy
  • Analyst Count
  • GNTY 2
  • ESPR 6
  • Target Price
  • GNTY $44.50
  • ESPR $6.50
  • AVG Volume (30 Days)
  • GNTY 45.5K
  • ESPR 5.0M
  • Earning Date
  • GNTY 10-20-2025
  • ESPR 08-05-2025
  • Dividend Yield
  • GNTY 2.06%
  • ESPR N/A
  • EPS Growth
  • GNTY 38.57
  • ESPR N/A
  • EPS
  • GNTY 3.15
  • ESPR N/A
  • Revenue
  • GNTY $127,325,000.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • GNTY $10.99
  • ESPR $10.59
  • Revenue Next Year
  • GNTY $4.83
  • ESPR N/A
  • P/E Ratio
  • GNTY $15.43
  • ESPR N/A
  • Revenue Growth
  • GNTY 10.12
  • ESPR N/A
  • 52 Week Low
  • GNTY $32.04
  • ESPR $0.69
  • 52 Week High
  • GNTY $49.02
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • GNTY 65.32
  • ESPR 72.25
  • Support Level
  • GNTY $45.22
  • ESPR $2.13
  • Resistance Level
  • GNTY $48.60
  • ESPR $2.29
  • Average True Range (ATR)
  • GNTY 0.91
  • ESPR 0.13
  • MACD
  • GNTY 0.35
  • ESPR 0.00
  • Stochastic Oscillator
  • GNTY 93.07
  • ESPR 81.36

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: